New oral anticoagulants were more frequently (214/156 vs. 5/20) used in centers admitting less than 200 patients per year, which was statistically significant (p = 0.046).
centers admitting ≥ 200 patients/year
centers admitting less than 200 patients/year
interested in joining randomized trials evaluating any of the methods used in VTE prophylaxis